Video

Dr. Cavnar on Surgical Differences Between Right- and Left-Sided Tumors in CRC

Michael J. Cavnar, MD, discusses ​surgical differences between right- and left-sided tumors in colorectal cancer.

Michael J. Cavnar, MD, assistant professor of surgery, University of Kentucky Markey Cancer Center, discusses ​surgical differences between right- and left-sided tumors in colorectal cancer (CRC).

Right-sided ​CRC tumors are the easiest to remove surgically​, explains Cavnar. ​Unless the tumor is bulky or advanced, patients who present with a right-sided tumor can likely undergo laparoscopic surgery to remove the tumor, Cavnar says. Moreover, laparoscopic surgery typically requires patients to be hospitalized for 3 to 4 days and the recovery period is usually short. 

Conversely, left-sided tumor ​resections tend to be more complicated​, says Cavnar. Tumors that are located on the upper​-left region of the colon are usually able to ​be remove​d surgically and don’t ​involve a diverting ileostomy. However, neoadjuvant radiation may be required in rectal cancer. Moreover, ​surgical anastomosis has a higher ​risk in this setting and is frequently protected with a diverting ileostomy, which requires an additional surgery to reverse, Cavnar concludes.

Related Videos
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Alastair Thompson, BSc, MBChB, MD, FRCS
C. Ola Landgren, MD, PhD
Sara M. Tolaney, MD, MPH
Adam M. Brufsky, MD, PhD, FACP
Justin M. Watts, MD
Sara M. Tolaney, MD, MPH
Leah Backhus, MD, MPH, FACS, professor, University Medical Line, Cardiothoracic Surgery, co-director, Thoracic Surgery Clinical Research Program, associate program director, Thoracic Track, CT Surgery Residency Training Program, Thelma and Henry Doelger Professor of Cardiovascular Surgery, Stanford Medicine; chief, Thoracic Surgery, VA Palo Alto
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Medical Oncology, director, Center for Thoracic Cancers, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine